SCHEMBL5742673

SCHEMBL5742673

CC(=O)/C(=N\O)c1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
BCL2L1 Q07817 1/20 0.42
BAD Q92934 1/20 0.42
CYP1A2 P05177 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PTPN1 P18031 1/20 0.41
NPC1 O15118 1/20 0.41
HTR7 P34969 1/20 0.40
MAPT P10636 1/20 0.40
LMNA P02545 1/20 0.40
PTBP1 P26599 1/20 0.40
TRPA1 O75762 1/20 0.40
TYMP P19971 1/20 0.40
LTA4H P09960 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5742677 1.00 CES2 (0.48) CES2CES1CA1CA2BCL2L1
SCHEMBL11491554 0.81 ALDH1A1 (0.50) CES2CES1SMN1; SMN2RAB9AALDH1A1
SCHEMBL7836762 0.81 CES2 (0.50) CES2CES1CA1CA2BCL2L1
SCHEMBL7836764 0.81 CES2 (0.50) CES2CES1CA1CA2BCL2L1
SCHEMBL30443235 0.81 CES2 (0.62) CES2CES1CA1CA2BCL2L1
SCHEMBL11032602 0.81 HSD17B1 (0.48) CES2CA1CA2SMN1; SMN2ALDH1A1
SCHEMBL11491555 0.81 ALDH1A1 (0.50) CES2CES1SMN1; SMN2RAB9AALDH1A1
SCHEMBL8720671 0.79 HTT (0.50) CES2CES1CA1CA2CYP1A2
SCHEMBL8720674 0.79 HTT (0.50) CES2CES1CA1CA2CYP1A2
SCHEMBL6839869 0.78 GAA (0.63) CES2CES1CA1CA2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1727541-A1 IMIDAZOLE-BASED HMG-COA REDUCTASE INHIBITORS Warner-Lambert Company LLC (US) 2006-12-06 EP disclosed
WO-2005079790-A1 IMIDAZOLE-BASED HMG-COA REDUCTASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2005-09-01 WO disclosed